Strata Skin Sciences Inc reports results for the quarter ended June 30 - Earnings Summary

• Strata Skin Sciences Inc SSKN.OQ reported a quarterly adjusted loss of 60 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -3 cents. The mean expectation of two analysts for the quarter was for a loss of 29 cents per share. Wall Street expected results to range from -31 cents to -26 cents per share.

• Revenue fell 9.2% to $7.66 million from a year ago; analysts expected $8.56 million.

• Strata Skin Sciences Inc's reported EPS for the quarter was a loss of 60 cents​.

• The company reported a quarterly loss of $2.49 million.

• Strata Skin Sciences Inc shares had fallen by 21.0% this quarter and lost 37.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 26.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

• Wall Street's median 12-month price target for Strata Skin Sciences Inc is $9.00, about 79.9% above its last closing price of $1.81

This summary was machine generated from LSEG data August 13 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)